A robust experimental protocol for pharmacological fMRI in rats and mice

Journal of Neuroscience Methods

Volumn 204, Issue 1, 2012, Pages 9-18

  Ferrari, Livia ^a   Turrini, Giuliano ^a   Crestan, Valerio ^a   Bertani, Simone ^a   Cristofori, Patrizia ^b   Bifone, Angelo ^c   Gozzi, Alessandro ^c  

^a GSK   (Italy)

^b GLAXOSMITHKLINE   (United Kingdom)

^c CENTER FOR NANOTECHNOLOGY INNOVATION NEST   (Italy)

Author keywords

Anaesthesia; FMRI; Mouse; PhMRI; Rat; Surgery

Indexed keywords

AMPHETAMINE;

ANESTHESIA; ARTERIAL GAS; ARTICLE; BLOOD PRESSURE FLUCTUATION; BRAIN BLOOD VOLUME; BRAIN FUNCTION; BREATHING RATE; C57BL 6 MOUSE; CONTROLLED STUDY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HEMODYNAMICS; IMMOBILIZATION STRESS; MOTION ANALYSIS SYSTEM; MOUSE; NONHUMAN; PHARMACOLOGICAL MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT;

ANIMALS; BRAIN; BRAIN MAPPING; CENTRAL NERVOUS SYSTEM STIMULANTS; DEXTROAMPHETAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, INBRED C57BL; RATS; RATS, SPRAGUE-DAWLEY; SPECIES SPECIFICITY;

EID: 84855222302     PISSN: 01650270     EISSN: 1872678X     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2011.10.020     Document Type: Article

References (62)

1. Bifone A, Gozzi A. Functional and pharmacological MRI in understanding brain fucntion. In: Hagan J, editor. Molecular and functional models in neuropsychiatry. Springer; in press.
2. Boxerman J.L., Hamberg L.M., Rosen B.R., Weisskoff R.M. MR contrast due to intravascular magnetic susceptibility perturbations. Magn Reson Med 1995, 34:555-566.
3. 2, blood flow and blood volume in phMRI of cocaine. Proc. of thirtheenth ISMRM scientific meeting and exhibition 2004, 226.
4. Chen Y.-C.I., Mandeville J.B., Nguyen T.V., Talele A., Cavagna F., Jenkins B.G. Improved mapping of pharmacologically induced neuronal activation using the IRON technique with superparamagnetic blood pool agents. J Magn Reson Imaging 2001, 14:517-524.
5. Chen Y.C., Galpern W.R., Brownell A.L., Matthews R.T., Bogdanov M., Isacson O., et al. Detection of dopaminergic neurotransmitter activity using pharmacologic MRI: correlation with PET, microdialysis, and behavioral data. Magn Reson Med 1997, 38:389-398.
6. Du C., Tully M., Volkow N.D., Schiffer W.K., Yu M., Luo Z., et al. Differential effects of anesthetics on cocaine's pharmacokinetic and pharmacodynamic effects in brain. Eur J Neurosci 2009, 30:1565-1575.
7. Edvinsson L., Krause D.N. Cerebral blood flow and metabolism 2002, Lippincott Williams & Wilkins, Philadelphia, p. 521. 2nd ed.
8. Febo M., Segarra A.C., Nair G., Schmidt K., Duong T.Q., Ferris C.F. The neural consequences of repeated cocaine exposure revealed by functional MRI in awake rats. Neuropsychopharmacology 2005, 30:936-943.
9. Ferrari L., Crestan V., Sabattini G., Vinco F., Fontana S., Gozzi A. Brain penetration of local anaesthetics in the rat: implications for experimental neuroscience. J Neurosci Methods 2010, 186:143-149.
10. Gozzi A., Ceolin L., Schwarz A., Reese T., Bertani S., Bifone A. A multimodality investigation of cerebral haemodynamics and autoregulation in phMRI. Magn Reson Imaging 2007, 25:826-833.
11. Gozzi A., Crestan V., Turrini G., Clemens M., Bifone A. Antagonism at serotonin 5-HT2A receptors modulates functional activity of fonto-hippocampal circuit. Psychopharmacology 2010, 209:37-50.
12. Gozzi A., Herdon H., Schwarz A., Bertani S., Crestan V., Turrini G., et al. Pharmacological stimulation of NMDA receptors via co-agonist site suppresses fMRI response to phencyclidine in the rat. Psychopharmacology 2008, 201:273-284.
13. Gozzi A., Large C., Schwarz A., Bertani S., Crestan V., Bifone A. Differential effects of antipsychotic and glutamatergic agents on the phMRI response to phencyclidine. Neuropsychopharmacology 2008, 33:1690-1703.
14. Gozzi A., Tessari M., Lanzoni A., Cristofori P., Corsi M., Merlo P.E., et al. Neuroimaging evidence of altered fronto-cortical and striatal function after prolonged cocaine self-administration in the rat. Neuropsychopharmacology 2011, 36:2431-2434.
15. Gozzi A., Apar J., Giovanelli A., Bertollini C., Crestan V., Schwarz A.J., et al. A neural switch for active and passive fear. Neuron 2010, 67:656-666.
16. Gozzi A., Schwarz A., Reese T., Bertani S., Crestan V., Bifone A. Region-specific effects of nicotine on brain activity: a pharmacological MRI study in the drug-naïve rat. Neuropsychopharmacology 2006, 31:1690-1703.
17. Gozzi A., Schwarz A.J., Reese T., Crestan V., Bifone A. Drug-anaesthetic interaction in phMRI: the case of the pyschotomimetic agent phencyclidine. Magn Reson Imaging 2008, 26:999-1006.
18. Gozzi A., Turrini G., Piccoli L., Massagrande M., Amantini D., Antolini M., et al. Functional magnetic resonance imaging reveals different neural substrates for the effects of orexin-1 and orexin-2 receptor antagonists. PLoS ONE 2011, 6:e16406.
19. Huettel S., Song A.W., McCarthy G. Functional magnetic resonance imaging 2004, Sinauer, Sunderland.
20. Jenkins B.G., Chen Y-CI, Mandeville J.B. Pharmacological magnetic resonance imaging (phMRI). Biomedical imaging in experimental neuroscience 2003, 155-209. CRC Press, New York. N. van Bruggen, T. Roberts (Eds.).
21. Jones M., Berwick J., Hewson-Stoate N., Gias C., Mayhew J. The effect of hypercapnia on the neural and hemodynamic responses to somatosensory stimulation. NeuroImage 2005, 27:609-623.
22. Kalisch R., Elbel G.K., Gossl C., Czisch M., Auer D.P. Blood pressure changes induced by arterial blood withdrawal influence bold signal in anesthesized rats at 7Tesla: implications for pharmacologic MRI. NeuroImage 2001, 14:891-898.
23. Kim S.G., Ugurbil K. High-resolution functional magnetic resonance imaging of the animal brain. Methods 2003, 30:28-41.
24. Kline D.D., Yang T., Huang P.L., Prabhakar N.R. Altered respiratory responses to hypoxia in mutant mice deficient in neuronal nitric oxide synthase. J Physiol 1998, 511:273-287.
25. Krege J.H., Hodgin J.B., Hagaman J.R., Smithies O. A noninvasive computerized tail-cuff system for measuring blood pressure in mice. Hypertension 1995, 25:1111-1115.
26. Lee J.G., Hudetz A.G., Smith J.J., Hillard C.J., Bosnjak Z.J., Kampine J.P. The effects of halothane and isoflurane on cerebrocortical microcirculation and autoregulation as assessed by laser-Doppler flowmetry. Anesth Analg 1994, 79:58-65.
27. Leslie R.A., James R.F. Pharmacological magnetic resonance imaging: a new application for functional MRI. Trends Pharmacol Sci 2000, 21:314-318.
28. Ma Y., Smith D., Hof P.R., Foerster B., Hamilton S., Blackband S.J., et al. In vivo 3D digital atlas database of the adult C57BL/6J mouse brain by magnetic resonance microscopy. Front Neuroanat 2008, 2:1.
29. Mandeville J.B., Marota J.J.A., Kosofsky B.E., Keltner J.R., Weissleder R., Rosen B., et al. Dynamic functional imaging of relative cerebral blood volume during rat forepaw stimulation. Magn Reson Med 1998, 39:615-624.
30. Marota J.J.A., Mandeville J.B., Weisskoff R., Moskowitz M.A., Rosen B., Kosofsky B.E. Cocaine activation discriminates dopaminergic projections by temporal response: an fMRI study in rat. NeuroImage 2000, 11:13-23.
31. Mathew R.J., Wilson W.H. Dextroamphetamine-induced changes in regional cerebral blood flow. Psychopharmacology 1985, 87:298-302.
32. Micheli F., Bonanomi G., Blaney F.E., Braggio S., Capelli A.M., Checchia A., et al. 1,2,4-Triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D(3) receptor antagonists. J Med Chem 2007, 50:5076-5089.
33. Mueggler T., Baumann D., Rausch M., Rudin M. Bicuculline-induced brain activation in mice detected by functional magnetic resonance imaging. Magn Reson Med 2001, 46:292-298.
34. Peeters R.R., Tindemans I., De Schutter E., Van der Linden A. Comparing BOLD fMRI signal changes in the awake and anesthetized rat during electrical forepaw stimulation. Magn Reson Imaging 2001, 19:821-826.
35. Pepelko W.E., Dixon G.A. Arterial blood gases in conscious rats exposed to hypoxia, hypercapnia, or both. J Appl Physiol 1975, 38:581-587.
36. Perles-Barbacaru T.A., Procissi D., Demyanenko A.V., Hall F.S., Uhl G.R., Jacobs R.E. Quantitative pharmacologic MRI: mapping the cerebral blood volume response to cocaine in dopamine transporter knockout mice. NeuroImage 2011, 55:622-628.
37. Preece M.A., Sibson N.R., Raley J.M., Blamire A., Styles P., Sharp T. Region-specific effects of a tyrosine-free amino acid mixture on amphetamine-induced changes in BOLD fMRI signal in the rat brain. Synapse 2007, 61:925-932.
38. Ramos-Cabrer P., Weber R., Wiedermann D., Hoehn M. Continuous noninvasive monitoring of transcutaneous blood gases for a stable and persistent BOLD contrast in fMRI studies in the rat. NMR Biomed 2005, 18:440-446.
39. Rausch M., Baumann D., Weber J., Sauter A., Rudin M. Hemodynamic changes in rat brain following pharmacological stimulation by amphetamine: correlation of fMRI signals and cerebral glucose utilization. Book of abstracts: tenth annual meeting of the international Society of Magnetic Resonance in Medicine, vol. 10 2002, 1362.
40. Rigalli A., Di Loreto V. Experimental surgical models in the laboratory rat 2009, CRC Press, London. 2009 ed.
41. Salord F., Keita H., Lecharny J.B., Henzel D., Desmonts J.M., Mantz J. Halothane and isoflurane differentially affect the regulation of dopamine and gamma-aminobutyric acid release mediated by presynaptic acetylcholine receptors in the rat striatum. Anesthesiology 1997, 86:632-641.
42. Schmidt K., Febo M., Shen Q., Luo F., Sicard K., Ferris C., et al. Hemodynamic and metabolic changes induced by cocaine in anesthetized rat observed with multimodal functional MRI. Psychopharmacology 2006, 185:479-486.
43. Schwarz A., Gozzi A., Reese T., Bertani S., Crestan V., Hagan J., et al. Selective dopamine D(3) receptor antagonist SB-277011-A potentiates phMRI response to acute amphetamine challenge in the rat brain. Synapse 2004, 54:1-10.
44. Schwarz A.J., Danckaert A., Reese T., Gozzi A., Paxinos G., Watson C., et al. A stereotaxic MRI template set for the rat brain with tissue class distribution maps and co-registered anatomical atlas: application to pharmacological MRI. NeuroImage 2006, 32:538-550.
45. Schwarz A.J., Gozzi A., Bifone A. Community structure and modularity in networks of correlated brain activity. Magn Reson Imaging 2008, 26:914-920.
46. Schwarz A.J., Gozzi A., Bifone A. Community structure in networks of functional connectivity: resolving functional organization in the rat brain with pharmacological MRI. NeuroImage 2009, 47:302-311.
47. Schwarz A.J., Gozzi A., Reese T., Bifone A. Functional connectivity in the pharmacologically activated brain: resolving networks of correlated responses to d-amphetamine. Magn Reson Med 2007, 57:704-713.
48. Schwarz A.J., Reese T., Gozzi A., Bifone A. Functional MRI using intravascular contrast agents: detrending of the relative cerebrovascular (rCBV) time course. Magn Reson Imaging 2003, 21:1191-1200.
49. Schwarz A.J., Whitcher B., Gozzi A., Reese T., Bifone A. Study-level wavelet cluster analysis and data-driven signal models in pharmacological MRI. J Neurosci Methods 2006, 159:346-360.
50. Schwarz A.J., Zocchi A., Reese T., Gozzi A., Garzotti M., Varnier G., et al. Concurrent pharmacological MRI and in situ microdialysis of cocaine reveal a complex relationship between the central hemodynamic response and local dopamine concentration. NeuroImage 2004, 23:296-304.
51. Schwarz A.J., Gozzi A., Reese T., Bifone A. In vivo mapping of functional connectivity in neurotransmitter systems using pharmacological MRI. NeuroImage 2007, 34:1627-1636.
52. Sicard K., Shen Q., Brevard M.E., Sullivan R., Ferris C.F., King J.A., et al. Regional cerebral blood flow and BOLD responses in conscious and anesthetized rats under basal and hypercapnic conditions: implications for functional MRI studies. J Cereb Blood Flow Metab 2003, 23:472-481.
53. 2 in spontaneously breathing animals. NeuroImage 2005, 25:850-858.
54. Silva A.C., Liu J.V., Hirano Y., Leoni R.F., Merkle H., Mackel J.B., et al. Longitudinal functional magnetic resonance imaging in animal models. Methods Mol Biol 2011, 711:281-302.
55. Stark R.A., Nahrwold M.L., Cohen P.J. Blind oral tracheal intubation of rats. J Appl Physiol 1981, 51:1355-1356.
56. Steward C.A., Marsden C.A., Prior M.J., Morris P.G., Shah Y.B. Methodological considerations in rat brain BOLD contrast pharmacological MRI. Psychopharmacology (Berl) 2005, 180:687-704.
57. Tuor U.I., McKenzie E., Tomanek B. Functional magnetic resonance imaging of tonic pain and vasopressor effects in rats. Magn Reson Imaging 2002, 20:707-712.
58. Van der Linden A., Van Camp N., Ramos-Cabrer P., Hoehn M. Current status of functional MRI on small animals: application to physiology, pathophysiology, and cognition. NMR Biomed 2007, 20:522-545.
59. Weber R., Ramos-Cabrer P., Wiedermann D., van Camp N., Hoehn M. A fully noninvasive and robust experimental protocol for longitudinal fMRI studies in the rat. NeuroImage 2006, 29:1303-1310.
60. Worsley K.J., Evans A.C., Marrett S., Neelin P. A three-dimensional statistical analysis for CBF activation studies in human brain. J Cereb Blood Flow Metab 1992, 12:900-918.
61. Yang S.P., Krasney J.A. Cerebral blood flow and metabolic responses to sustained hypercapnia in awake sheep. J Cereb Blood Flow Metab 1995, 15:115-123.
62. Zausinger S., Baethmann A., Schmid-Elsaesser R. Anesthetic methods in rats determine outcome after experimental focal cerebral ischemia: mechanical ventilation is required to obtain controlled experimental conditions. Brain Res Protoc 2002, 9:112-121.